Impact of Inflammatory Response Modifiers on the Incidence of Hospital-Acquired Infections in Patients with COVID-19.

Infectious Diseases and Therapy
Fernanda MeiraJosé Antonio Martínez

Abstract

The study aim was to assess the influence of inflammatory response modifiers, including anti-interleukin-6 (IL-6) biologics and corticosteroids, on the incidence of hospital-acquired infections in patients with coronavirus disease 2019 (COVID-19). Case-control study performed at a university hospital from February 26 to May 26, 2020. Cases were defined as patients with COVID-19 who developed hospital-acquired infections. For each case, two controls were selected among patients without infections. Cases and controls were matched obeying three criteria in a hierarchical sequence: length of hospital stay up until the first infection; comorbidity; and need for Intensive care unit (ICU) admission. Conditional logistic regression analysis was used to estimate the association of exposures with being a case. A total of 71 cases and 142 controls were included. Independent predictors for acquiring a hospital infection were chronic liver disease [odds ratio (OR) 16.56, 95% CI 1.87-146.5, p = 0.012], morbid obesity (OR 6.11, 95% CI 1.06-35.4, p = 0.043), current or past smoking (OR 4.15, 95% CI 1.45-11.88, p = 0.008), exposure to hydroxychloroquine (OR 0.2, 95% CI 0.041-1, p = 0.053), and invasive mechanical ventilation (OR 61.5, 95% CI 11...Continue Reading

References

Jun 1, 1988·American Journal of Infection Control·J S GarnerJ M Hughes
Jul 17, 2007·International Journal of Antimicrobial Agents·Jean-Marc RolainDidier Raoult
Aug 15, 2018·Frontiers in Immunology·Nicholas HemingDjillali Annane
Dec 7, 2019·The Cochrane Database of Systematic Reviews·Djillali AnnaneBram Rochwerg
May 3, 2020·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Timothy M RawsonAlison Holmes
Jul 1, 2020·Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases·S HughesL S P Moore
Jul 11, 2020·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Carolina Garcia-VidalUNKNOWN COVID19-Researchers
Jul 12, 2020·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Emily C SomersJason M Pogue
Jul 18, 2020·The New England Journal of Medicine·UNKNOWN RECOVERY Collaborative GroupMartin J Landray
Aug 4, 2020·Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases·Carolina Garcia-VidalUNKNOWN COVID-19 Researchers Group
Aug 14, 2020·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Christiane Maria Prado JeronimoUNKNOWN Metcovid Team
Aug 14, 2020·Journal of Medical Virology·Natasha N PettitKenneth Pursell
Aug 25, 2020·The Lancet Rheumatology·Giovanni GuaraldiCristina Mussini
Sep 3, 2020·JAMA : the Journal of the American Medical Association·Pierre-François DequinUNKNOWN CAPE COVID Trial Group and the CRICS-TriGGERSep Network
Sep 3, 2020·JAMA : the Journal of the American Medical Association·Bruno M TomaziniUNKNOWN COALITION COVID-19 Brazil III Investigators
Oct 21, 2020·JAMA Internal Medicine·Olivier HermineUNKNOWN CORIMUNO-19 Collaborative Group
Oct 22, 2020·Emerging Infectious Diseases·Kieren A MarrCarolina Garcia-Vidal
Oct 22, 2020·The New England Journal of Medicine·John H StoneUNKNOWN BACC Bay Tocilizumab Trial Investigators
Nov 24, 2020·Critical Care Explorations·Tyler C LewisDaniel H Sterman
Dec 12, 2020·The New England Journal of Medicine·Andre C KalilUNKNOWN ACTT-2 Study Group Members
Dec 18, 2020·The New England Journal of Medicine·Carlos SalamaShalini V Mohan
Dec 30, 2020·The Journal of Antimicrobial Chemotherapy·Marco FalconeUNKNOWN Pisa COVID-19 Study Group
Jan 22, 2021·BMJ : British Medical Journal·Viviane C VeigaUNKNOWN Coalition covid-19 Brazil VI Investigators
Jan 26, 2021·The Lancet. Respiratory Medicine·Giulio Cavalli, Lorenzo Dagna
Feb 26, 2021·The New England Journal of Medicine·UNKNOWN REMAP-CAP InvestigatorsLennie P G Derde
Feb 26, 2021·The New England Journal of Medicine·Ivan O RosasAtul Malhotra
Mar 9, 2021·Journal of Infection and Chemotherapy : Official Journal of the Japan Society of Chemotherapy·Jogender KumarArushi Yadav

❮ Previous
Next ❯

Citations

Nov 18, 2021·Clinical Microbiology Reviews·Fabián SalazarAdilia Warris

❮ Previous
Next ❯

Software Mentioned

SPSS

Related Concepts

Related Feeds

Antimalarial Agents

Antimalarial agents, also known as antimalarials, are designed to prevent or cure malaria. Discover the latest research on antimalarial agents here.

Antimalarial Agents (ASM)

Antimalarial agents, also known as antimalarials, are designed to prevent or cure malaria. Discover the latest research on antimalarial agents here.

Related Papers

The New England Journal of Medicine
The New England Journal of Medicine
C K Bhatia
Southern Medical Journal
H D Riley
© 2021 Meta ULC. All rights reserved